FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315708944> ?p ?o ?g. }

• W4315708944 endingPage "e239" @default.
• W4315708944 startingPage "e239" @default.
• W4315708944 abstract "Objective: Melatonin may have a role in the pathophysiology of a set of three diseases categories that interact with each other, namely psychosocial stress disorders, sleep/circadian rhythm disturbances, and cardiometabolic diseases, forming a therapeutic target triad for melatonin (stress-sleep/circadian- cardiometabolic disorders triad). Establishing a relationship between the pharmacological target and disease has become a fundamental goal for scientists, as it is crucial for developing novel medicines or repurposing existing ones. We investigated the target prediction of melatonin for the stress-sleep/circadian- cardiometabolic disorders triad using machine learning predictive models. Design and Methods: The Open Targets Genetics, ChEMBL, PhenoDigm, PheWAS Catalog and Europe PMC databases were utilized to examine melatonin target tractability and prediction of the stress-sleep-cardiovascular triad. Diseases with association records for melatonin MT1, MT2 and MT3 receptors have been categorized into sleep, cardiovascular, diabetic pathology and psychosocial disorders discarding other pathologies. The collections of direct and indirect relationships were queried to generate tables containing the names of diseases, supporting data sources, and the number of evidences for each association and data source. Graphs were built by applying igraph library-based scripts and have been depicted applying the Gephi ForceAtlas algorithm. Results: To date, 144 phase I to IV trials for melatonin or agonists have been completed, and 78 phase 4 trials are ongoing or completed, for drugs with investigational or approved indications targeting melatonin receptors based on their proposed mode of action on stress-sleep/circadian- cardiometabolic disorders triad. The scientific evidence on the pathogenic linkages for melatonin within the stress-sleep- cardiometabolic disorders triad is identified. This study not only identified novel biologically plausible relationships that may justify further translational research for melatonin, but it also demonstrated an effective usage of data from several databases. Conclusion: Molecular biomarkers, 24-hour blood pressure, nocturnal blood pressure and heart rate, psychosocial markers, cardiometabolic risk scores, and multiple biomarker modeling are all referenced for this triad. Based on these findings, we propose combining outcome measures with biomarkers from different triad diseases when designing clinical trials for melatonin or agonists for a triad disorder." @default.
• W4315708944 created "2023-01-12" @default.
• W4315708944 creator A5023076814 @default.
• W4315708944 creator A5046000787 @default.
• W4315708944 creator A5053716128 @default.
• W4315708944 creator A5067762471 @default.
• W4315708944 creator A5082154047 @default.
• W4315708944 creator A5091583669 @default.
• W4315708944 date "2023-01-01" @default.
• W4315708944 modified "2023-10-03" @default.
• W4315708944 title "PS-P02-1: MACHINE LEARNING PREDICTS MELATONIN TARGETS ON THE PSYCHOSOCIAL STRESS-SLEEP/CIRCADIAN-CARDIOMETABOLIC DISORDERS TRIAD" @default.
• W4315708944 doi "https://doi.org/10.1097/01.hjh.0000915164.40169.23" @default.
• W4315708944 hasPublicationYear "2023" @default.
• W4315708944 type Work @default.
• W4315708944 citedByCount "0" @default.
• W4315708944 crossrefType "journal-article" @default.
• W4315708944 hasAuthorship W4315708944A5023076814 @default.
• W4315708944 hasAuthorship W4315708944A5046000787 @default.
• W4315708944 hasAuthorship W4315708944A5053716128 @default.
• W4315708944 hasAuthorship W4315708944A5067762471 @default.
• W4315708944 hasAuthorship W4315708944A5082154047 @default.
• W4315708944 hasAuthorship W4315708944A5091583669 @default.
• W4315708944 hasBestOaLocation W43157089441 @default.
• W4315708944 hasConcept C118552586 @default.
• W4315708944 hasConcept C121446783 @default.
• W4315708944 hasConcept C126322002 @default.
• W4315708944 hasConcept C150966472 @default.
• W4315708944 hasConcept C2778182776 @default.
• W4315708944 hasConcept C60644358 @default.
• W4315708944 hasConcept C71924100 @default.
• W4315708944 hasConcept C86803240 @default.
• W4315708944 hasConceptScore W4315708944C118552586 @default.
• W4315708944 hasConceptScore W4315708944C121446783 @default.
• W4315708944 hasConceptScore W4315708944C126322002 @default.
• W4315708944 hasConceptScore W4315708944C150966472 @default.
• W4315708944 hasConceptScore W4315708944C2778182776 @default.
• W4315708944 hasConceptScore W4315708944C60644358 @default.
• W4315708944 hasConceptScore W4315708944C71924100 @default.
• W4315708944 hasConceptScore W4315708944C86803240 @default.
• W4315708944 hasIssue "Suppl 1" @default.
• W4315708944 hasLocation W43157089441 @default.
• W4315708944 hasLocation W43157089442 @default.
• W4315708944 hasOpenAccess W4315708944 @default.
• W4315708944 hasPrimaryLocation W43157089441 @default.
• W4315708944 hasRelatedWork W2045375075 @default.
• W4315708944 hasRelatedWork W2069356418 @default.
• W4315708944 hasRelatedWork W2092341993 @default.
• W4315708944 hasRelatedWork W2166021020 @default.
• W4315708944 hasRelatedWork W2274501452 @default.
• W4315708944 hasRelatedWork W2364231590 @default.
• W4315708944 hasRelatedWork W2377603382 @default.
• W4315708944 hasRelatedWork W2474529888 @default.
• W4315708944 hasRelatedWork W4290353875 @default.
• W4315708944 hasRelatedWork W4709805 @default.
• W4315708944 hasVolume "41" @default.
• W4315708944 isParatext "false" @default.
• W4315708944 isRetracted "false" @default.
• W4315708944 workType "article" @default.